With 0.76 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.19 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.53 whereas the lowest price it dropped to was $0.445. The 52-week range on QTI shows that it touched its highest point at $14.40 and its lowest point at $0.35 during that stretch. Beta for the stock currently stands at -0.21.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of QTI was up-trending over the past week, with a rise of 42.17%, but this was up by 3.67% over a month. Three-month performance dropped to -24.61% while six-month performance fell -33.51%. The stock lost -95.43% in the past year, while it has gained 1.97% so far this year.
Float and Shares Shorts:
At present, 21.44 million QTI shares are outstanding with a float of 13.91 million shares on hand for trading. On 2024-10-31, short shares totaled 75347.0, which was 34.999998999999995 higher than short shares on 1727654400. In addition to Dr. Raluca Dinu Ph.D. as the firm’s CEO & Director, Mr. Anastas Budagov serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.07603 of QTI’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, QTI reported revenue of $955970.0 and operating income of -$2327188.0. The EBITDA in the recently reported quarter was -$2290685.0 and diluted EPS was -$0.17.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
